You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 10,981,923


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,981,923
Title:Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Abstract: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-- trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
Inventor(s): Allian; Ayman (Newbury Park, CA), Borchardt; Thomas B. (Kenosha, WI), Jayanth; Jayanthy (Buffalo Grove, IL), Marroum; Patrick J. (Springfield, VA), Mayer; Peter T. (Libertyville, IL), Mulhern; Mathew M. (Lake Villa, IL), Nordstrom; Fredrik Lars (Ridgefield, CT), Sheikh; Ahmad Y. (Lake Forest, IL)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:16/905,667
Patent Claim Types:
see list of patent claims
Composition; Compound; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,981,923

Introduction

United States Patent 10,981,923, granted on April 20, 2021, is a significant patent in the pharmaceutical domain. To fully comprehend its implications, it is crucial to delve into the patent's scope, claims, and the broader patent landscape.

Patent Basics

Before diving into the specifics of Patent 10,981,923, it is essential to understand the basic components of a patent. A patent typically includes a detailed description of the invention, drawings or diagrams, and claims that define the scope of the invention[1].

Patent 10,981,923 Overview

This patent pertains to a specific pharmaceutical compound and its preparation methods. Here is a brief overview:

Invention Description

The patent describes a compound identified as "(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)benzamide" and its synthetic methods. This compound is likely intended for therapeutic use, given its complex chemical structure and the context of related pharmaceutical patents[4].

Claims

The claims section of the patent is critical as it defines the legal boundaries of the invention. For Patent 10,981,923, the claims include:

  • Independent Claims: These are the broadest claims that stand alone and define the core invention.
  • Dependent Claims: These claims are narrower and depend on the independent claims, often adding specific details or limitations.

The independent claims typically focus on the chemical structure of the compound and its preparation methods, while dependent claims may specify particular aspects such as dosage forms, administration routes, or specific therapeutic uses[4].

Scope of the Patent

The scope of a patent is determined by its claims and is a crucial aspect of patent law.

Claim Language and Scope

The scope of Patent 10,981,923 is defined by the language used in its claims. Research has shown that the clarity and breadth of claim language significantly impact patent quality and the examination process. Narrower claims with clear language are generally associated with a higher probability of grant and a shorter examination process[3].

Independent Claim Length and Count

Studies have indicated that metrics such as independent claim length and count can be used to measure patent scope. For Patent 10,981,923, analyzing these metrics could provide insights into the patent's breadth and potential for litigation or licensing issues[3].

Patent Examination Process

The examination process for Patent 10,981,923 would have involved several key steps:

Filing and Initial Review

The patent application would have been filed with the U.S. Patent and Trademark Office (USPTO) and reviewed for formalities and compliance with patent regulations[1].

Substantive Examination

During the substantive examination, the patent examiner would have evaluated the novelty, non-obviousness, and utility of the invention. This process often involves negotiations between the applicant and the examiner to refine the claims and ensure they meet the statutory requirements[1].

Claim Narrowing

The examination process tends to narrow the scope of patent claims, especially in terms of claim length and count. This narrowing helps to ensure that the patent is granted for a specific and well-defined invention, reducing the likelihood of overly broad claims that could impede innovation[3].

Patent Landscape

Understanding the broader patent landscape is essential for assessing the significance and potential impact of Patent 10,981,923.

Related Patents and Prior Art

The patent references several prior patents and publications, indicating a complex and evolving field of research. These references help to establish the novelty of the invention and its position within the existing body of knowledge[4].

Competitors and Licensing

In the pharmaceutical industry, patents like 10,981,923 can be critical for market exclusivity. Companies may engage in licensing agreements or litigation to protect their intellectual property. The scope and claims of this patent will influence its potential for licensing and the competitive landscape[2].

Maintenance and Expiration

Patents require maintenance fees to remain in force. For Patent 10,981,923, the maintenance fees and potential expiration date are crucial for understanding its long-term impact.

Maintenance Fees

The USPTO requires periodic maintenance fees to keep a patent in force. Failure to pay these fees can result in the patent expiring prematurely[1].

Expiration Date

The patent's expiration date will determine when the invention enters the public domain. This is typically 20 years from the earliest filing date of the patent application, but can vary based on adjustments during the examination process[1].

Conclusion

United States Patent 10,981,923 is a complex and technically detailed patent that defines a specific pharmaceutical compound and its preparation methods. Understanding its scope, claims, and the broader patent landscape is crucial for both the patent holder and competitors in the pharmaceutical industry.

Key Takeaways

  • Patent Scope: Defined by the claims, with narrower claims generally associated with a higher probability of grant and shorter examination process.
  • Claim Language: Clear and specific language is essential for patent quality and reducing litigation risks.
  • Examination Process: Involves filing, initial review, substantive examination, and potential claim narrowing.
  • Patent Landscape: Includes prior art, related patents, and potential licensing or litigation with competitors.
  • Maintenance and Expiration: Regular maintenance fees are required, and the patent will expire 20 years from the earliest filing date.

FAQs

  1. What is the main subject of United States Patent 10,981,923?

    • The main subject is a specific pharmaceutical compound and its synthetic methods.
  2. How are the claims of a patent defined?

    • Claims are defined by the language used in the patent application, with independent claims being the broadest and dependent claims adding specific details.
  3. What metrics can be used to measure patent scope?

    • Metrics such as independent claim length and count can be used to measure patent scope.
  4. Why is the examination process important for patent claims?

    • The examination process helps to refine the claims, ensuring they meet statutory requirements and are not overly broad.
  5. How long does a patent typically remain in force?

    • A patent typically remains in force for 20 years from the earliest filing date of the patent application, provided maintenance fees are paid.

Sources

  1. USPTO - Patents
  2. Drug Patent Watch - Patent 10,981,923
  3. Hoover Institution - Patent Claims and Patent Scope
  4. Google Patents - US 10,981,923 B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,981,923

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie RINVOQ LQ upadacitinib SOLUTION;ORAL 218347-001 Apr 26, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-001 Aug 16, 2019 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-002 Jan 14, 2022 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.